These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6750780)

  • 1. Low-dose penicillamine treatment of RA. Comparison of 600 mg and 300 mg regimens.
    Nissilä M; Nuotio P; von Essen R; Mäkisara P
    Scand J Rheumatol; 1982; 11(3):161-4. PubMed ID: 6750780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL
    Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen.
    Hill HF; Hill AG; Day AT; Brown RM; Golding JR; Lyle WH
    Ann Rheum Dis; 1979 Oct; 38(5):429-33. PubMed ID: 518142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillamine treatment in rheumatoid arthritis. A retrospective study.
    Börjesson O; Knutsson LP; Svensson B
    Acta Med Scand; 1980; 207(1-2):93-6. PubMed ID: 7368979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 8. Penicillamine for treatment of rheumatoid arthritis.
    Gordon MH; Ehrlich GE
    JAMA; 1974 Sep; 229(10):1342-3. PubMed ID: 4604882
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multicentric ambulatory trial of Trolovol (D-penicillamine) in chronic polyarthritis].
    Tautz VI
    Z Rheumatol; 1975; 34(3-4):87-93. PubMed ID: 806188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine in rheumatoid disease: a long-term study.
    Day AT; Golding JR; Lee PN; Butterworth AD
    Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficulties in the use of D-penicillamine in the treatment of rheumatoid arthritis.
    Stockman A; Richter D; Barraclough D; Muirden KD; Macdonald I; Kincaid-Smith P
    Aust N Z J Med; 1979 Oct; 9(5):495-503. PubMed ID: 294903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine in 50 rheumatoid arthritic patients intolerant or unresponsive to gold or penicillamine.
    Jenkins EA; Ansell BM; Hall MA; Liyanage SP
    Clin Rheumatol; 1985 Sep; 4(3):278-80. PubMed ID: 4064585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
    Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
    Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive joint damage during penicillamine therapy for rheumatoid arthritis.
    Scott DL; Greenwood A; Bryans R; Huskisson EC
    Rheumatol Int; 1988; 8(3):135-9. PubMed ID: 3175451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-penicillamine-induced polymyositis in patients with rheumatoid arthritis.
    Takahashi K; Ogita T; Okudaira H; Yoshinoya S; Yoshizawa H; Miyamoto T
    Arthritis Rheum; 1986 Apr; 29(4):560-4. PubMed ID: 3707633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.